mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.5 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.5 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.5 |